These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31275164)

  • 21. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy.
    Zhao J; Yang S; Jing R; Jin H; Hu Y; Wang J; Gu M; Niu H; Zhang S; Chen L; Hua W
    Front Cardiovasc Med; 2020; 7():597546. PubMed ID: 33240942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-ordered dysregulated ceRNA networks reveal disease progression and diagnostic biomarkers in ischemic and dilated cardiomyopathy.
    Bai Z; Sun H; Li X; Wu J; Yuan H; Zhang G; Yang H; Shi H
    Cell Death Discov; 2021 Oct; 7(1):296. PubMed ID: 34657123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R; Neumann F; Ullrich R; Neumüller J; Podesser BK; Neumann M; Schreiner W
    Cardiovasc Pathol; 2005; 14(3):135-44. PubMed ID: 15914298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptomal analysis of failing and nonfailing human hearts.
    Steenman M; Chen YW; Le Cunff M; Lamirault G; Varró A; Hoffman E; Léger JJ
    Physiol Genomics; 2003 Jan; 12(2):97-112. PubMed ID: 12429867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An altered left ventricle protein profile in human ischemic cardiomyopathy revealed in comparative quantitative proteomics.
    Yi X; Jiang DS; Feng G; Jiang XJ; Zeng HL
    Kardiol Pol; 2019 Oct; 77(10):951-959. PubMed ID: 31434864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Analysis of Bulk and Single-Cell RNA Sequencing Data Reveals Cell Types Involved in Heart Failure.
    Shi X; Zhang L; Li Y; Xue J; Liang F; Ni HW; Wang X; Cai Z; Shen LH; Huang T; He B
    Front Bioeng Biotechnol; 2021; 9():779225. PubMed ID: 35071201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure.
    Shao X; Zhang X; Yang L; Zhang R; Zhu R; Feng R
    Epigenetics; 2021 Aug; 16(8):917-932. PubMed ID: 33016206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.
    Böhm M; Gierschik P; Jakobs KH; Pieske B; Schnabel P; Ungerer M; Erdmann E
    Circulation; 1990 Oct; 82(4):1249-65. PubMed ID: 2169357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of heart failure on nucleolar organization and protein expression in human hearts.
    Roselló-Lletí E; Rivera M; Cortés R; Azorín I; Sirera R; Martínez-Dolz L; Hove L; Cinca J; Lago F; González-Juanatey JR; Salvador A; Portolés M
    Biochem Biophys Res Commun; 2012 Feb; 418(2):222-8. PubMed ID: 22244875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of beta1D-integrin function in human ischemic cardiomyopathy.
    Pfister R; Acksteiner C; Baumgarth J; Burst V; Geissler HJ; Margulies KB; Houser S; Bloch W; Flesch M
    Basic Res Cardiol; 2007 May; 102(3):257-64. PubMed ID: 17186162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes.
    Nishtala K; Phong TQ; Steil L; Sauter M; Salazar MG; Kandolf R; Kroemer HK; Felix SB; Völker U; Klingel K; Hammer E
    Proteomics; 2011 Nov; 11(22):4310-20. PubMed ID: 21954127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart.
    Dieterich S; Bieligk U; Beulich K; Hasenfuss G; Prestle J
    Circulation; 2000 Jan 4-11; 101(1):33-9. PubMed ID: 10618301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy.
    Spänig S; Kellermann K; Dieterlen MT; Noack T; Lehmann S; Borger MA; Garbade J; Barac YD; Emrich F
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3.
    Reitz CJ; Tavassoli M; Kim DH; Shah S; Lakin R; Teng ACT; Zhou YQ; Li W; Hadipour-Lakmehsari S; Backx PH; Emili A; Oudit GY; Kuzmanov U; Gramolini AO
    Proc Natl Acad Sci U S A; 2023 May; 120(19):e2212118120. PubMed ID: 37126683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different contribution of endothelial nitric oxide in the relaxation of human coronary arteries of ischemic and dilated cardiomyopathic hearts.
    Thorin E
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):227-32. PubMed ID: 11210005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
    Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
    Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A; Bloch W; Antonyan A; Goebel H; Fries JU; Schlensak C; Beyersdorf F; Geissler HJ
    Lymphology; 2010 Sep; 43(3):110-7. PubMed ID: 21226413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study.
    Baán JA; Varga ZV; Leszek P; Kuśmierczyk M; Baranyai T; Dux L; Ferdinandy P; Braun T; Mendler L
    J Transl Med; 2015 Jan; 13():1. PubMed ID: 25591711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase 2 and 3 as risk biomarkers for dilated cardiomyopathy associated heart failure.
    Su H; Hu K; Liu Z; Chen K; Xu J
    Ann Palliat Med; 2021 Dec; 10(12):12554-12565. PubMed ID: 35016406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.